Prostate specific antigen levels and clinical response to low dose dexamethasone for hormone-refractory metastatic prostate carcinoma

This publication has 14 references indexed in Scilit:

• Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome
  Journal of Urology, 1993
• Pituitary Adrenal and Gonadal Endocrine Suppression for the Primary Treatment of Prostate Cancer
  British Journal of Urology, 1990
• Suppression of Plasma Androgen Levels with a Combination Therapy of Depot-Estrogen (Turisteron^R) and Dexamethasone^R in Patients with Prostatic Cancer
  Experimental and Clinical Endocrinology & Diabetes, 1989
• The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients
  British Journal of Cancer, 1988
• Carcinoma of the prostate. Hormonal therapy
  Cancer, 1987
• Androgen Suppression by Hydrocortisone without Aminoglutethimide in Orchiectomised Men with Prostatic Cancer
  British Journal of Urology, 1987
• Hormonal Therapy in Metastatic Prostatic Cancer
  Published by Springer Nature ,1987
• Adrenal androgen blockade in relapsed prostate cancer
  European Journal of Cancer and Clinical Oncology, 1985
• STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITRO
  Journal of Endocrinology, 1974
• Cortisone Treatment in Advanced Carcinoma of the Prostate
  Journal of Urology, 1954